Trading Signals: AGN Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. May. 8, 2020)(Allergan plc)
| AGN latest price $217.9244 (-1.73%) ($217.7589 - $221.7808) on Tue. Sep. 5, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.96% (three month average) | RSI | 36 | Latest Price | $217.9244(-1.73%) | Stocks Behave Similarly | Similar Stock List | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support AGN advance at 0% a week (0% probability) IBB(50%) XLV(49%) SPY(44%) VT(44%) XBI(44%) | Factors Impacting AGN price | AGN will decline at least -0.48% in a week (0% probabilities). VIXM(-29%) TLT(-17%) UUP(-16%) SHY(-3%) GDXJ(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.48% (StdDev 0.96%) | Hourly BBV | 0 () | Intraday Trend | -1.4% | | | |
|
Resistance Level | $221.13 | 5 Day Moving Average | $219.78(-0.84%) | 10 Day Moving Average | $218.59(-0.3%) | 20 Day Moving Average | $221.13(-1.45%) | To recent high | -12.4% | To recent low | 0.9% | Market Cap | $71.85b | | | | Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland. |